Form D · Other
Huntress Labs Inc
Columbia, MD · CIK 0001805379
Offering snapshot reported Jun 20, 2024 · SEC filing
- Reported sold
- $180M Offering amount: $180M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 7, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 20, 2024 | Initial | $180,000,000 | No comparison | 8 | SEC filing |
| May 23, 2023 | Initial | $59,999,992 | No comparison | 5 | SEC filing |
| May 17, 2021 | Initial | $39,999,990 | No comparison | Not reported | SEC filing |
| Mar 4, 2020 | Initial | $12,146,657 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-516406
Preferred Stock can convert to underlying shares of Common Stock.
Source: Form D, filed Jun 20, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Arnold | Executive |
| Ernie Bio | Director |
| Christopher D. Bisnett | Director, Executive |
| John Ferrell | Executive |
| Kyle R. Hanslovan | Director, Executive |
| Alex Kurland | Director |
| Everett Randle | Director |
| Marcos E. Torres | Executive |
| Suken Vakil | Director |
| Casber Wang | Director |
Issuer details
Industry: Other (See others in industry)
Address:
6996 Columbia Gateway Dr, Ste 101
Columbia, MD, 21046
Columbia, MD, 21046